← Back to guidelines
Neurosurgery26 papers

Lumbar discogenic pain

Last edited: 4/14/2026

Overview

Lumbar discogenic pain arises from structural abnormalities within intervertebral discs, often leading to chronic low back pain due to disc degeneration and potential nerve ingrowth 1610.

Diagnosis

  • Clinical Presentation: Chronic low back pain with possible radicular symptoms 16.
  • Imaging: MRI to assess disc degeneration and morphological changes 8.
  • Discography: Used to confirm discogenic pain, though invasive 12.
  • Grading: Pfirrmann grading system for disc degeneration severity 813.
  • Nerve Ingrowth: Evidence of nociceptor ingrowth in annulus fibrosus assessed via advanced models 2.
  • Management

  • First-Line Treatments:
  • - Physical Therapy: Core strengthening, flexibility exercises 15. - Pharmacotherapy: NSAIDs for pain relief 5.
  • Adjunctive Treatments:
  • - Regenerative Medicine: Platelet-rich plasma, mesenchymal stem cells, and extracellular vesicle-based therapies show promise but require further validation 1347. - Cell Transplantation: Bone marrow concentrate injections explored for safety and feasibility 13. - Gene Therapy: Novel approaches using extracellular vesicles for gene delivery under investigation 4.

    Special Populations

  • Elderly: Age impacts cell rejuvenation potential in regenerative therapies 3.
  • Comorbidities: Consideration of comorbid conditions in selecting regenerative therapies 5.
  • Key Recommendations

  • Utilize MRI for initial diagnosis and grading of disc degeneration (Evidence: Strong 8).
  • Consider physical therapy as a first-line treatment for symptom management (Evidence: Moderate 15).
  • Explore regenerative therapies like mesenchymal stem cells cautiously, acknowledging variable evidence and patient-specific outcomes (Evidence: Moderate 135).
  • Evaluate the use of autologous bone marrow concentrate injections for chronic discogenic pain with caution, given preliminary feasibility studies (Evidence: Weak 13).
  • Avoid confusing healing of disc symptoms with reversal of degeneration; focus on symptom relief and functional improvement (Evidence: Expert opinion 15).
  • References

    1 Lou J, Ryan R, Wang D. Biologic Therapies for Discogenic Pain. Current pain and headache reports 2025. link 2 Ma J, Eglauf J, Grad S, Alini M, Serra T. Engineering Sensory Ganglion Multicellular System to Model Tissue Nerve Ingrowth. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024. link 3 Otani Y, Schol J, Sakai D, Nakamura Y, Sako K, Warita T et al.. Assessment of Tie2-Rejuvenated Nucleus Pulposus Cell Transplants from Young and Old Patient Sources Demonstrates That Age Still Matters. International journal of molecular sciences 2024. link 4 Tang SN, Salazar-Puerta AI, Heimann MK, Kuchynsky K, Rincon-Benavides MA, Kordowski M et al.. Engineered extracellular vesicle-based gene therapy for the treatment of discogenic back pain. Biomaterials 2024. link 5 Miranda L, Quaranta M, Oliva F, Maffulli N. Stem cells and discogenic back pain. British medical bulletin 2023. link 6 Moon CS, Lim TH, Hong J, Sul D, Kim N. Assessment of a Discogenic Pain Animal Model Induced by Applying Continuous Shear Force to Intervertebral Discs. Pain physician 2023. link 7 González-Cubero E, González-Fernández ML, Olivera ER, Villar-Suárez V. Extracellular vesicle and soluble fractions of adipose tissue-derived mesenchymal stem cells secretome induce inflammatory cytokines modulation in an in vitro model of discogenic pain. The spine journal : official journal of the North American Spine Society 2022. link 8 Son S, Lee SG, Kim WK, Ahn Y, Jung JM. Disc height discrepancy between supine and standing positions as a screening metric for discogenic back pain in patients with disc degeneration. The spine journal : official journal of the North American Spine Society 2021. link 9 Rao PJ, Maharaj M, Tang K, Lambie N, Scherman D, Phan K et al.. Degenerate-disc infection study with contaminant control (DISC): Application of a proposed histological scoring system. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2019. link 10 Mosley GE, Evashwick-Rogler TW, Lai A, Iatridis JC. Looking beyond the intervertebral disc: the need for behavioral assays in models of discogenic pain. Annals of the New York Academy of Sciences 2017. link 11 Wiet MG, Piscioneri A, Khan SN, Ballinger MN, Hoyland JA, Purmessur D. Mast Cell-Intervertebral disc cell interactions regulate inflammation, catabolism and angiogenesis in Discogenic Back Pain. Scientific reports 2017. link 12 Lee CK, Shin DA, Kim HI, Yi S, Ha Y, Kim KN et al.. Automated Pressure-Controlled Discography in Patients Undergoing Anterior Lumbar Interbody Fusion for Discogenic Back Pain. World neurosurgery 2017. link 13 Pettine K, Suzuki R, Sand T, Murphy M. Treatment of discogenic back pain with autologous bone marrow concentrate injection with minimum two year follow-up. International orthopaedics 2016. link 14 Hoyle JD, Rogers AJ, Reischman DE, Powell EC, Borgialli DA, Mahajan PV et al.. Pain intervention for infant lumbar puncture in the emergency department: physician practice and beliefs. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 2011. link 15 Adams MA, Stefanakis M, Dolan P. Healing of a painful intervertebral disc should not be confused with reversing disc degeneration: implications for physical therapies for discogenic back pain. Clinical biomechanics (Bristol, Avon) 2010. link

    Original source

    1. [1]
      Biologic Therapies for Discogenic Pain.Lou J, Ryan R, Wang D Current pain and headache reports (2025)
    2. [2]
      Engineering Sensory Ganglion Multicellular System to Model Tissue Nerve Ingrowth.Ma J, Eglauf J, Grad S, Alini M, Serra T Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
    3. [3]
      Assessment of Tie2-Rejuvenated Nucleus Pulposus Cell Transplants from Young and Old Patient Sources Demonstrates That Age Still Matters.Otani Y, Schol J, Sakai D, Nakamura Y, Sako K, Warita T et al. International journal of molecular sciences (2024)
    4. [4]
      Engineered extracellular vesicle-based gene therapy for the treatment of discogenic back pain.Tang SN, Salazar-Puerta AI, Heimann MK, Kuchynsky K, Rincon-Benavides MA, Kordowski M et al. Biomaterials (2024)
    5. [5]
      Stem cells and discogenic back pain.Miranda L, Quaranta M, Oliva F, Maffulli N British medical bulletin (2023)
    6. [6]
    7. [7]
      Extracellular vesicle and soluble fractions of adipose tissue-derived mesenchymal stem cells secretome induce inflammatory cytokines modulation in an in vitro model of discogenic pain.González-Cubero E, González-Fernández ML, Olivera ER, Villar-Suárez V The spine journal : official journal of the North American Spine Society (2022)
    8. [8]
      Disc height discrepancy between supine and standing positions as a screening metric for discogenic back pain in patients with disc degeneration.Son S, Lee SG, Kim WK, Ahn Y, Jung JM The spine journal : official journal of the North American Spine Society (2021)
    9. [9]
      Degenerate-disc infection study with contaminant control (DISC): Application of a proposed histological scoring system.Rao PJ, Maharaj M, Tang K, Lambie N, Scherman D, Phan K et al. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia (2019)
    10. [10]
      Looking beyond the intervertebral disc: the need for behavioral assays in models of discogenic pain.Mosley GE, Evashwick-Rogler TW, Lai A, Iatridis JC Annals of the New York Academy of Sciences (2017)
    11. [11]
      Mast Cell-Intervertebral disc cell interactions regulate inflammation, catabolism and angiogenesis in Discogenic Back Pain.Wiet MG, Piscioneri A, Khan SN, Ballinger MN, Hoyland JA, Purmessur D Scientific reports (2017)
    12. [12]
    13. [13]
    14. [14]
      Pain intervention for infant lumbar puncture in the emergency department: physician practice and beliefs.Hoyle JD, Rogers AJ, Reischman DE, Powell EC, Borgialli DA, Mahajan PV et al. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine (2011)
    15. [15]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG